; (B) training workers; and (C) developing new prescription drugs, new active pharmaceutical ingredients, or new antibiotics. (f) Device In this section, the term device has the meaning given to such term in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). (g) Sunset This section (other than subsection (e)) shall cease to have effect beginning on the date that is 10 years after the date of the enactment of this Act. (h) Unused funds returned to the general fund of the treasury If any amounts remain in the Fund after the date described in subsection (f), the Secretary of the Treasury shall transfer such amounts to the general fund of the Treasury. 6. Registry of drugs manufactured outside the United States The Federal Food, Drug, and Cosmetic Act is amended by inserting after section 524A of such Act ( 21 U.S.C. 360n–1 ) the following new section: 524B. Registry of drugs manufactured outside the United States (a) In general The Secretary shall compile and maintain a registry of all drugs approved under subsection (c) or (j) of section 505 of this Act or licensed under sub-section (a) or (k) of section 351 of the Public Health Service Act, and any active pharmaceutical ingredients in such drugs, that are manufactured outside of the United States. The Secretary shall update such registry at least biannually. (b) Additional list (1) In general In conjunction with the registry under subsection (a), the Secretary shall compile and maintain a list of those drugs included in the registry for which 50 percent or more of their active pharmaceutical ingredients are manufactured in locations within a single country outside the United States. (2) Contents The list of drugs under paragraph (1) shall— (A) identify both the drugs and the associated sole-source country; (B) be updated at least bi-annually